Literature DB >> 21761461

Comparison of Gd-DTPA and Gd-BOPTA for studying renal perfusion and filtration.

Mike Notohamiprodjo1, Michael Pedersen, Christian Glaser, Andreas D Helck, Klaus-Peter Lodemann, Bente Jespersen, Michael Fischereder, Maximilian F Reiser, Steven P Sourbron.   

Abstract

PURPOSE: To measure the systematic error in perfusion and filtration parameters derived from magnetic resonance (MR) renography caused by protein binding of MR contrast agents.
MATERIALS AND METHODS: Eight healthy Danish Landrace pigs were examined with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). In four pigs a bolus of gadopentetate-dimeglumine (Gd-DTPA; no protein binding) was injected, followed by gadobenate-dimeglumine (Gd-BOPTA; 10% protein binding). The order was reversed in the other four pigs. A two-compartment filtration model was generalized to allow for protein binding and fitted to whole-cortex region of interest (ROI) curves. Single-kidney plasma flow and volume, tubular flow (or GFR), and tubular transit time of both agents were compared.
RESULTS: The data show a strong systematic underestimation (P < 0.001) in GFR by Gd-BOPTA (33 ± 7.2%), and no significant differences (P > 0.05) in plasma flow (2.2 ± 18%), plasma volume (-1.7 ± 7.8%) and tubular transit time (3.1 ± 7.2%). The order of injection had no significant effect.
CONCLUSION: Theory and experiments agree that perfusion parameters of both agents are comparable, whereas GFR is underestimated with Gd-BOPTA due to the dependence of relaxivity on protein content. Hence, GFR cannot be measured with protein-bound contrast agents, but the proposed dual-agent protocol may produce new functional indices measuring protein filtration.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21761461     DOI: 10.1002/jmri.22640

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  CT perfusion technique for assessment of early kidney allograft dysfunction: preliminary results.

Authors:  A Helck; M Wessely; M Notohamiprodjo; U Schönermarck; E Klotz; M Fischereder; F Schön; K Nikolaou; D A Clevert; M Reiser; C Becker
Journal:  Eur Radiol       Date:  2013-05-10       Impact factor: 5.315

2.  Dynamic Contrast Enhancement (DCE) MRI-Derived Renal Perfusion and Filtration: Basic Concepts.

Authors:  Michael Pedersen; Pietro Irrera; Walter Dastrù; Frank G Zöllner; Kevin M Bennett; Scott C Beeman; G Larry Bretthorst; Joel R Garbow; Dario Livio Longo
Journal:  Methods Mol Biol       Date:  2021

Review 3.  The role of functional imaging in the era of targeted therapy of renal cell carcinoma.

Authors:  Margarita Braunagel; Anno Graser; Maximilian Reiser; Mike Notohamiprodjo
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

4.  X-ray phase-contrast tomography of renal ischemia-reperfusion damage.

Authors:  Astrid Velroyen; Martin Bech; Irene Zanette; Jolanda Schwarz; Alexander Rack; Christiane Tympner; Tanja Herrler; Claudia Staab-Weijnitz; Margarita Braunagel; Maximilian Reiser; Fabian Bamberg; Franz Pfeiffer; Mike Notohamiprodjo
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

Review 5.  Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations.

Authors:  Michael J Thrippleton; Walter H Backes; Steven Sourbron; Michael Ingrisch; Matthias J P van Osch; Martin Dichgans; Franz Fazekas; Stefan Ropele; Richard Frayne; Robert J van Oostenbrugge; Eric E Smith; Joanna M Wardlaw
Journal:  Alzheimers Dement       Date:  2019-04-25       Impact factor: 21.566

6.  Gadofosveset-based biomarker of tissue albumin concentration: Technical validation in vitro and feasibility in vivo.

Authors:  Owen C Richardson; Octavia Bane; Marietta L J Scott; Steven F Tanner; John C Waterton; Steven P Sourbron; Timothy J Carroll; David L Buckley
Journal:  Magn Reson Med       Date:  2014-02-11       Impact factor: 4.668

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.